期刊论文详细信息
BMC Genomics
Supplemental carnitine affects the microRNA expression profile in skeletal muscle of obese Zucker rats
Klaus Eder1  Robert Ringseis1  Janine Keller1 
[1] Institute of Animal Nutrition and Nutritional Physiology, Justus-Liebig-University, Heinrich-Buff-Ring 26-32, Giessen 35392, Germany
关键词: Obese Zucker rat;    Skeletal muscle;    Microarray;    microRNA expression profile;    Carnitine;   
Others  :  857055
DOI  :  10.1186/1471-2164-15-512
 received in 2013-11-12, accepted in 2014-06-17,  发布年份 2014
PDF
【 摘 要 】

Background

In the past, numerous studies revealed that supplementation with carnitine has multiple effects on performance characteristics and gene expression in livestock and model animals. The molecular mechanisms underlying these observations are still largely unknown. Increasing evidence suggests that microRNAs (miRNAs), a class of small non-coding RNA molecules, play an important role in post-transcriptional regulation of gene expression and thereby influencing several physiological and pathological processes. Based on these findings, the aim of the present study was to investigate the influence of carnitine supplementation on the miRNA expression profile in skeletal muscle of obese Zucker rats using miRNA microarray analysis.

Results

Obese Zucker rats supplemented with carnitine had higher concentrations of total carnitine in plasma and muscle than obese control rats (P < 0.05). miRNA expression profiling in skeletal muscle revealed a subset of 152 miRNAs out of the total number of miRNAs analysed (259) were identified to be differentially regulated (adjusted P-value < 0.05) by carnitine supplementation. Compared to the obese control group, 111 miRNAs were up-regulated and 41 down-regulated by carnitine supplementation (adjusted P-value < 0.05). 14 of these miRNAs showed a log2 ratio ≥ 0.5 and 7 miRNAs showed a log2 ratio ≤ −0.5 (adjusted P-value < 0.05). After confirmation by qRT-PCR, 11 miRNAs were found to be up-regulated and 6 miRNAs were down-regulated by carnitine supplementation (P < 0.05). Furthermore, a total of 1,446 target genes within the validated miRNAs were revealed using combined three bioinformatic algorithms. Analysis of Gene Ontology (GO) categories and KEGG pathways of the predicted targets revealed that carnitine supplementation regulates miRNAs that target a large set of genes involved in protein-localization and -transport, regulation of transcription and RNA metabolic processes, as well as genes involved in several signal transduction pathways, like ubiquitin-mediated proteolysis and longterm depression, are targeted by the miRNAs regulated by carnitine supplementation.

Conclusion

The present study shows for the first time that supplementation of carnitine affects a large set of miRNAs in skeletal muscle of obese Zucker rats suggesting a novel mechanism through which carnitine exerts its multiple effects on gene expression, which were observed during the past.

【 授权许可】

   
2014 Keller et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140723063329666.pdf 990KB PDF download
38KB Image download
87KB Image download
97KB Image download
123KB Image download
496KB Image download
52KB Image download
【 图 表 】

【 参考文献 】
  • [1]Kerner J, Hoppel C: Fatty acid import into mitochondria. Biochim Biophys Acta 2000, 1486:1-17.
  • [2]Owen KQ, Nelssen JL, Goodband RD, Weeden TL, Blum SA: Effect of L-carnitine and soybean oil on growth performance and body composition of early-weaned pigs. J Anim Sci 1996, 74:1612-1619.
  • [3]Musser RE, Goodband RD, Tokach MD, Owen KQ, Nelssen JL, Blum SA, Dritz SS, Civis CA: Effects of L-carnitine fed during gestation and lactation on sow and litter performance. J Anim Sci 1999, 77:3289-3295.
  • [4]Heo K, Odle J, Han IK, Cho W, Seo S, van Heugten E, Pilkington DH: Dietary L-carnitine improves nitrogen utilization in growing pigs fed low energy, fat-containing diets. J Nutr 2000, 130:1809-1814.
  • [5]Eder K, Ramanau A, Kluge H: Effect of L-carnitine supplementation on performance parameters in gilts and sows. J Anim Physiol Anim Nutr (Berl) 2001, 85:73-80.
  • [6]Ramanau A, Kluge H, Spilke J, Eder K: Reproductive performance of sows supplemented with dietary L-carnitine over three reproductive cycles. Arch Tierernahr 2002, 56:287-296.
  • [7]Ringseis R, Keller J, Eder K: Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur J Nutr 2012, 51:1-18.
  • [8]Keller J, Ringseis R, Priebe S, Guthke R, Kluge H, Eder K: Effect of L-carnitine on the hepatic transcript profile in piglets as animal model. Nutr Metab (Lond) 2011, 8:76.
  • [9]Keller J, Ringseis R, Priebe S, Guthke R, Kluge H, Eder K: Dietary L-carnitine alters gene expression in skeletal muscle of piglets. Mol Nutr Food Res 2011, 55:419-429.
  • [10]Keller J, Ringseis R, Koc A, Lukas I, Kluge H, Eder K: Supplementation with l-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets. Animal 2012, 6:70-78.
  • [11]Keller J, Couturier A, Haferkamp M, Most E, Eder K: Supplementation of carnitine leads to an activation of the IGF-1/PI3K/Akt signalling pathway and down regulates the E3 ligase MuRF1 in skeletal muscle of rats. Nutr Metab (Lond) 2013, 10:28.
  • [12]Ambros V: The functions of animal microRNAs. Nature 2004, 431:350-355.
  • [13]Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 2004(116):281-297.
  • [14]Qin W, Shi Y, Zhao B, Yao C, Jin L, Ma J, Jin Y: miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 2010, 5:e9429.
  • [15]Shivdasani RA: MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006, 108:3646-3653.
  • [16]Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27:91-105.
  • [17]Filipowicz W, Bhattacharyya SN, Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008, 9:102-114.
  • [18]Wienholds E, Plasterk RH: MicroRNA function in animal development. FEBS Lett 2005, 579:5911-5922.
  • [19]Wu L, Fan J, Belasco JG: MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 2006, 103:4034-4039.
  • [20]Ørom UA, Nielsen FC, Lund AH: MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008, 30:460-471.
  • [21]Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N: Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
  • [22]Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
  • [23]Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C: MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 2007, 170:1831-1840.
  • [24]Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT: Altered microRNA expression in human heart disease. Physiol Genomics 2007, 31:367-373.
  • [25]Zhang B, Pan X, Cobb GP, Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302:1-12.
  • [26]Yildirim SS, Akman D, Catalucci D, Turan B: Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Cell Biochem Biophys 2013, 67:1397-1408.
  • [27]Shen H, Liu T, Fu L, Zhao S, Fan B, Cao J, Li X: Identification of microRNAs involved in dexamethasone-induced muscle atrophy. Mol Cell Biochem 2013, 381:105-113.
  • [28]Karere GM, Glenn JP, VandeBerg JL, Cox LA: Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons. BMC Genomics 2012, 13:320.
  • [29]Parra P, Serra F, Palou A: Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One 2010, 5:e13005.
  • [30]Couturier A, Ringseis R, Mooren FC, Krüger K, Most E, Eder K: Carnitine supplementation to obese Zucker rats prevents obesity-induced type II to type I muscle fiber transition and favors an oxidative phenotype of skeletal muscle. Nutr Metab (Lond) 2013, 10:48.
  • [31]Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM: Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008, 7:45-56.
  • [32]Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, Stevens RD, Hegardt FG, Muoio DM: Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem 2009, 284:22840-22852.
  • [33]Ringseis R, Mooren FC, Keller J, Couturier A, Wen G, Hirche F, Stangl GI, Eder K, Krüger K: Regular endurance exercise improves the diminished hepatic carnitine status in mice fed a high-fat diet. Mol Nutr Food Res 2011, 55(Suppl 2):193-202.
  • [34]Power RA, Hulver MW, Zhang JY, Dubois J, Marchand RM, Ilkayeva O, Muoio DM, Mynatt RL: Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia 2007, 50:824-832.
  • [35]Heo YR, Kang CW, Cha YS: L-Carnitine changes the levels of insulin-like growth factors (IGFs) and IGF binding proteins in streptozotocin-induced diabetic rat. J Nutr Sci Vitaminol (Tokyo) 2001, 47:329-334.
  • [36]Busquets S, Serpe R, Toledo M, Betancourt A, Marmonti E, Orpí M, Pin F, Capdevila E, Madeddu C, López-Soriano FJ, Mantovani G, Macciò A, Argilés JM: L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer. Clin Nutr 2012, 31:889-895.
  • [37]Di Marzio L, Moretti S, D'Alò S, Zazzeroni F, Marcellini S, Smacchia C, Alesse E, Cifone MG, De Simone C: Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation. Clin Immunol 1999, 92:103-110.
  • [38]Kita K, Kato S, Amanyaman M, Okumura J, Yokota H: Dietary L-carnitine increases plasma insulin-like growth factor-I concentration in chicks fed a diet with adequate dietary protein level. Br Poult Sci 2002, 43:117-121.
  • [39]Doberenz J, Birkenfeld C, Kluge H, Eder K: Effects of L-carnitine supplementation in pregnant sows on plasma concentrations of insulin-like growth factors, various hormones and metabolites and chorion characteristics. J Anim Physiol Anim Nutr (Berl) 2006, 90:487-499.
  • [40]Woodworth JC, Tokach MD, Nelssen JL, Goodband RD, Dritz SS, Koo SI, Minton JE, Owen KQ: Influence of dietary L-carnitine and chromium picolinate on blood hormones and metabolites of gestating sows fed one meal per day. J Anim Sci 2007, 85:2524-2537.
  • [41]Brown KR, Goodband RD, Tokach MD, Dritz SS, Nelssen JL, Minton JE, Higgins JJ, Lin X, Odle J, Woodworth JC, Johnson BJ: Effects of feeding L-carnitine to gilts through day 70 of gestation on litter traits and the expression of insulin-like growth factor system components and L-carnitine concentration in foetal tissues. J Anim Physiol Anim Nutr (Berl) 2008, 92:660-667.
  • [42]Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
  • [43]Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
  • [44]Hirche F, Fischer M, Keller J, Eder K: Determination of carnitine, its short chain acyl esters and metabolic precursors trimethyllysine and gamma-butyrobetaine by quasi-solid phase extraction and MS/MS detection. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:2158-2162.
  • [45]Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, Smyth GK: A comparison of background correction methods for two-colour microarrays. Bioinformatics 2007, 23:2700-2707.
  • [46]Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210.
  • [47]Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 2001, 25:402-408.
  • [48]da Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
  文献评价指标  
  下载次数:4次 浏览次数:6次